494 related articles for article (PubMed ID: 9234798)
41. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
[TBL] [Abstract][Full Text] [Related]
42. Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2010 Feb; 28(7):1668-72. PubMed ID: 20026449
[TBL] [Abstract][Full Text] [Related]
43. Transgene as vaccine for chlamydia.
Brunham RC; Zhang Dj
Am Heart J; 1999 Nov; 138(5 Pt 2):S519-22. PubMed ID: 10539864
[TBL] [Abstract][Full Text] [Related]
44. Antibodies to Variable Domain 4 Linear Epitopes of the
Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
[No Abstract] [Full Text] [Related]
45. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
Zheng Y; Zhao WM; Wang H; Zhou YB; Luan Y; Qi M; Cheng YZ; Tang W; Liu J; Yu H; Yu XP; Fan YJ; Yang X
Biochem Cell Biol; 2007 Apr; 85(2):218-26. PubMed ID: 17534403
[TBL] [Abstract][Full Text] [Related]
46. Immunogenic and protective ability of the two developmental forms of Chlamydiae in a mouse model of infertility.
Pal S; Rangel J; Peterson EM; de la Maza LM
Vaccine; 1999 Nov; 18(7-8):752-61. PubMed ID: 10547436
[TBL] [Abstract][Full Text] [Related]
47. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
[TBL] [Abstract][Full Text] [Related]
48. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
[TBL] [Abstract][Full Text] [Related]
49. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
[TBL] [Abstract][Full Text] [Related]
50. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
51. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
[TBL] [Abstract][Full Text] [Related]
52. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
[TBL] [Abstract][Full Text] [Related]
53. Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®.
Cheng C; Cruz-Fisher MI; Tifrea D; Pal S; Wizel B; de la Maza LM
Vaccine; 2011 Mar; 29(13):2437-43. PubMed ID: 21276442
[TBL] [Abstract][Full Text] [Related]
54. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
55. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein.
Tuffrey M; Alexander F; Conlan W; Woods C; Ward M
J Gen Microbiol; 1992 Aug; 138 Pt 8():1707-15. PubMed ID: 1527511
[TBL] [Abstract][Full Text] [Related]
56. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.
Kari L; Whitmire WM; Crane DD; Reveneau N; Carlson JH; Goheen MM; Peterson EM; Pal S; de la Maza LM; Caldwell HD
J Immunol; 2009 Jun; 182(12):8063-70. PubMed ID: 19494332
[TBL] [Abstract][Full Text] [Related]
57. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.
Cheng C; Pal S; Tifrea D; Jia Z; de la Maza LM
Microbes Infect; 2014 Mar; 16(3):244-52. PubMed ID: 24291713
[TBL] [Abstract][Full Text] [Related]
58. [Immunogenicity of multi-epitopes gene of major outer membrane protein of Chlamydia trachomatis].
Zhu SL; Shi ZH; Li WS; Chen J; Zhang LF
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Mar; 43(3):232-6. PubMed ID: 19534931
[TBL] [Abstract][Full Text] [Related]
59. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
Peterson EM; Cheng X; Motin VL; de la Maza LM
Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
[TBL] [Abstract][Full Text] [Related]
60. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
